BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8908253)

  • 1. Overexpression of tenascin in cholesteatoma and external auditory meatal skin compared to retroauricular epidermis.
    Schilling V; Lang S; Rasp G; Mack B; Nerlich A
    Acta Otolaryngol; 1996 Sep; 116(5):741-6. PubMed ID: 8908253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
    Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
    Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of transforming growth factor-beta-expressing cells and comparison with major extracellular components in aural cholesteatoma.
    Lang S; Schilling V; Wollenberg B; Mack B; Nerlich A
    Ann Otol Rhinol Laryngol; 1997 Aug; 106(8):669-73. PubMed ID: 9270431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of S100A1 in external auditory canal cholesteatoma.
    Naim R; Hormann K
    Oncol Rep; 2006 Oct; 16(4):671-5. PubMed ID: 16969478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
    Lee RJ; Sidey C; Narula AA; James RF
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
    Li H; Jiang P; Wang L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of the proliferative capacity of cholesteatomas].
    Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
    Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical investigations on external auditory canal cholesteatomas.
    Adamczyk M; Sudhoff H; Jahnke K
    Otol Neurotol; 2003 Sep; 24(5):705-8. PubMed ID: 14501442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H; Huang CC
    Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A; Sittinger M; Bujia J
    Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults].
    Olszewska E; Chodynicki S; Chyczewski L
    Otolaryngol Pol; 2003; 57(1):85-9. PubMed ID: 12741150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localisation of basic fibroblast growth factor in cholesteatoma matrix: an immunochemical study.
    Hamed MA; Sayed RH; Shiogama K; Eltaher MA; Suzuki K; Nakata S
    J Laryngol Otol; 2019 Mar; 133(3):183-186. PubMed ID: 30808433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Markers of epidermal proliferation in middle ear cholesteatoma].
    Hassmann-Poznańska E; Skotnicka B; Dziecioł J
    Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Air-exposed tissue culture of human middle ear epithelium and meatal epidermis: a method to study the advancing front of cholesteatoma.
    Albers-op t' Hof BM; Peek FA; Huisman MA; Grote JJ
    Acta Otolaryngol; 2002 Oct; 122(7):720-5. PubMed ID: 12484648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of long non-coding RNA HOTAIR expression in middle ear cholesteatoma].
    Li Q; Wang HQ; Chen YQ; Xiong S; Zeng L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):250-253. PubMed ID: 29871236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.